Why the study?
Does cardiac resynchronization therapy improve thyroid function in patients with advanced chronic heart failure?
Does cardiac resynchronization therapy improve thyroid function in patients with advanced chronic heart failure?
Cardiac resynchronization therapy is associated with improved thyroid hormone profiles (fT3 and fT3/fT4 ratio) in heart failure patients who achieve reverse remodeling.
Thyroid hormone improvements may accompany reverse remodeling after CRT; hypothesis-generating for direct endocrine effects of resynchronization.
BACKGROUND: Heart failure patients frequently have thyroid function abnormalities. Cardiac resynchronization therapy (CRT) is a major treatment for patients with advanced chronic heart failure. We aimed to investigate the effects of CRT on thyroid functions. HYPOTHESIS: CRT improves thyroid functions. METHODS: Fifty-seven patients (42 male, 15 female; mean age 58 ± 13 y) undergoing CRT were included in the study. Serum levels of thyroid hormones and echocardiographic parameters were measured before and 6 months after CRT. A response to CRT was defined as a reverse remodeling detected by a relative increase of ≥15% in left ventricular ejection fraction. RESULTS: The clinical status and functional capacity of the patients in the remodeling group were improved significantly. The mean New York Heart Association class was reduced from 3.2 ± 0.4 to 2.2 ± 0.4 (P<0.001). The free triiodothyronine (fT3) level increased from 2.67 pg/mL to 2.97 pg/mL in the reverse remodeling group (P = 0.005). The fT3/fT4 ratio increased from 1.81 to 2.34 (P = 0.006). CONCLUSIONS: CRT improves fT3 levels and fT3/fT4 ratio, which may play an important role in reverse remodeling.
No takes yet. Share an insight, caveat, or question.
Çelikyurt et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: